Bayer Appoints New Head of U.S. Operations
21 Junio 2023 - 9:53AM
Noticias Dow Jones
By Dean Seal
Bayer has tapped the head of its pharmaceuticals business for
the Americas to take over all U.S. operations.
The German pharmaceutical and agricultural giant said Wednesday
that Sebastian Guth will retain his leadership over the
pharmaceuticals arm for the U.S. and Canada while ascending to the
role of president for Bayer U.S.
Oversight of Bayer's pharmaceutical business in Latin America
will shift to Heike Prinz, the head of commercial operations for
the company's pharmaceutical operations in Europe, the Middle East
and Africa.
The leadership shuffles follows the departure of former Bayer
U.S. President Patrick Lockwood-Taylor, who left earlier this month
to become CEO of Perrigo.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
June 21, 2023 10:38 ET (14:38 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Bayer Aktiengesellschaft (PK) (OTCMarkets): 0 recent articles
Más de Bayer Aktiengesellschaft (PK) Artículos de Noticias